Código QR (código de barras bidimensional)

Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study

Abstract Background Checkpoint inhibitors (CPIs) are widely used in cancer treatment, with transformative impacts on survival. They nonetheless carry a significant risk of toxicity in the form of immune-related adverse events (IrAEs), which may be sustained and life-altering. IrAEs may require high-...

ver descrição completa

Na minha lista:
Principais autores: Abigail Gault, Linda Hogarth, Kristian C Williams, Alastair Greystoke, Neil Rajan, Ally Speight, Christopher A Lamb, Alison Bridgewood, Lisa-Jayne Brown-Schofield, Fiona Rayner, John D Isaacs, Jérémie Nsengimana, Christopher J Stewart, Amy E Anderson, Ruth Plummer, Arthur G Pratt
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2024-06-01
coleção:BMC Cancer
Assuntos:
Checkpoint inhibitor
Immunotherapy
Cancer
Immune related adverse events
Pathogenesis
Cohort study
Acesso em linha:https://doi.org/10.1186/s12885-024-12468-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados